NCT00051792

Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of yoga in reducing shortness of breath in people with chronic obstructive pulmonary disease (COPD). Patients in this study must have moderate to severe COPD and be primarily limited by shortness of breath.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jan 2003

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2003

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

January 16, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 17, 2003

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2004

Completed
Last Updated

August 18, 2006

Status Verified

August 1, 2006

First QC Date

January 16, 2003

Last Update Submit

August 16, 2006

Conditions

Pulmonary Disease, Chronic ObstructiveLung Diseases, ObstructivePulmonary EmphysemaChronic Bronchitis

Interventions

yogaBEHAVIORAL

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to commit to a 12-week yoga class in San Francisco, California
  • Moderate to severe COPD, clinically stable for at least 1 month prior to study entry
  • Forced Expiratory Volume at one minute (FEV1) \< 49% predicted after inhaled bronchodilator
  • Activities of daily living limited by shortness of breath
  • Ability to speak English and sign consent
  • Patients receiving supplemental oxygen will be acceptable if their O2 saturation can be maintained at \> 85% on \< 6 L/min of nasal oxygen

You may not qualify if:

  • Symptomatic illness (e.g., cancer, left heart failure, ischemic heart disease, neuromuscular disease, psychiatric illness)
  • Formal pulmonary rehabilitation training within 1 year prior to study entry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California

San Francisco, California, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveLung Diseases, ObstructivePulmonary EmphysemaBronchitis, Chronic

Interventions

Yoga

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBronchitisRespiratory Tract InfectionsInfectionsBronchial Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Virginia Carrieri-Kohlman, RN, DNSc

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH

Study Record Dates

First Submitted

January 16, 2003

First Posted

January 17, 2003

Study Start

January 1, 2003

Study Completion

July 1, 2004

Last Updated

August 18, 2006

Record last verified: 2006-08

Locations

US(1)